Click it and Unblock the Notifications
Just In
-
-
-
Don't Miss
-
Lovely Runner Episode 5 OTT Release Date, Time, Platform: When & Where To Watch? What To Expect? DEETS -
Stock To Buy: Multibagger Tata Stock Hits 20% Upper Circuit, Gains 37.22% In 1-Week; TP Rs 1100 -
Legends Cricket League: Manager charged with Match Fixing Allegations after International Stars launch complaint -
Redmi Pad SE With 90Hz Display, 8,000mAh Battery Launched in India -
Log9 Unveils Amphion & Nexmile – Revolutionizing EV Asset Management -
Students of the Canadian International School in Bangalore Raise Nearly 60 Lakh Rupees for Bangalore NGOs -
Arushi Sharma-Vaibhav Vishant Wedding, Love Aaj Kal 2 Actor Looks Resplendent In A Pastel Ethnic Outfit, Pics! -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Ranbaxy recieves approval to manufacture Esomeprazole in US
Mumbai, Feb 7 (UNI) Ranbaxy Laboratories 2008 has received tentative approval from the US Food and Drug Administration to manufacture and market Esomeprazole Magnesium Delayed-Release capsules in USA.
Esomeprazole is the second largest selling drug in USA with total annual market sales of USD 5.5 billion.
Ranbaxy believes that it has a first to file status on the drug, providing it with a potential 180 days marketing exclusivity, thereby offering a significant opportunity in the future, a release said.
Esomeprazole is indicated for the short-term treatment (four to eight weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis and for treatment of heartburn and other symptoms associated with gastroesophageal reflux disease.
UNI
AR
GR
SM1315
